Skip to main content
EQRxNews Page

EQRx Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Corporate Progress

By March 23, 2022No Comments

EQRx, Inc. (Nasdaq: EQRX), a new type of pharmaceutical company committed to developing and delivering innovative medicines to patients at radically lower prices, today reported financial results for the quarter and full year ended December 31, 2021 and provided an overview of recent corporate progress.

Read Article